Skip to main content
. 2023;77(5):377–383. doi: 10.5455/medarh.2023.77.377-383

Table 3. AP incidence in patients after peroral DAE.

Author Year N0. of cases AP after DAE
Honda et al(9) 2006 13 1(7.7%)
Kopáčová et al(12) 2007 35 1(2.9%)
Aktas et al(14) 2009 135 1(0.7%)
Zepeda-Gómez et al(17) 2011 92 3(3.3%)
Teshima et al(18) 2012 32 0(0%)
Shibuya et al(19) 2012 202 0(0%)
Itaba et al(20) 2013 44 1(2.3%)
Tsujikawa et al(23) 2015 84 3(3.6%)
Kopáčová et al(24) 2016 117 0(0%)
Matsushita et al(25) 2016 96 1(1.0%)